(Q43053234)

13 November 2017

Risk factors associated with renal lithiasis during uricosuric treatment of hyperuricemia in patients with gout (English)

1 reference

13 November 2017

1

1 reference

13 November 2017

Samuel Hernandez-Baldizon

series ordinal

2

1 reference

PubMed ID

20506124

13 November 2017

Ana M Herrero-Beites

series ordinal

3

1 reference

PubMed ID

20506124

13 November 2017

Miguel A Gonzalez-Gay

series ordinal

4

1 reference

13 November 2017

1 September 2010

1 reference

Arthritis Care and Research

13 November 2017

1 reference

13 November 2017

62

1 reference

13 November 2017

9

1 reference

13 November 2017

1299-1305

1 reference

Evaluation of uricosuric agents in chronic gout

13 November 2017

1 reference

Novel insights into the pathogenesis of uric acid nephrolithiasis

21 January 2018

1 reference

Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout

21 January 2018

1 reference

Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output

21 January 2018

1 reference

The alkaline tide phenomenon

21 January 2018

1 reference

Biochemical distinction between hyperuricosuric calcium urolithiasis and gouty diathesis

21 January 2018

1 reference

21 January 2018

1 reference

Hyperuricosuric calcium nephrolithiasis

21 January 2018

1 reference

Physicochemical metabolic characteristics for calcium oxalate stone formation in patients with gouty diathesis

21 January 2018

1 reference

The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance

21 January 2018

1 reference

Low urine pH: a novel feature of the metabolic syndrome.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ACR.20221

1 reference

13 November 2017

1 reference

PubMed ID

20506124